News
The co-founder of fertility-focused supplement brand, WeNatal, has donated over $25,000 worth of products to her community after losing her own home in LA's wildfires. Former Nike executive and WeNatal co-founder, Ronit Menashe, saw her family home in the Palisades destroyed during the fires which devastated Los Angeles earlier this month. Celebrity nutritionist, Brigid Titgemeier, [...]
A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated a clinically meaningful improvement in overall survival with TIVDAK treatment for patients with previously treated recurrent or metastatic cervical cancer compared to chemotherapy. According to the results, TIVDAK demonstrated [...]
Innovative Birmingham-based nutrition firm Rem3dy Health has been recognised in the first-ever “Sunday Times 100 Tech: Britain's fastest-growing private technology companies” list. The new rankings were compiled by the newspaper’s business reporters and private company data source, Beauhurst. They include firms that either sell their own proprietary technology or have developed technology that is vital [...]
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth platform, , is currently under FDA review and and developer Teal Health and said it hopes to increase uptake of screenings with the device. The industry has shifted toward [...]
Researchers have discovered that the loss of oestrogen and progesterone during menopause causes damage to bone cartilage and the cells that maintain it. However, they also found that bringing these hormone levels back to what they were before menopause can help protect the cartilage from breaking down. Osteoarthritis (OA) is a condition that disproportionally affects [...]
The recent Women and Equalities Committee (WEC) report further highlighted how the UK public healthcare system is failing to meet the needs of women—now they want to see solutions. For many women, the WEC report published late last year revealed little they didn’t already know. Women are constantly having their symptoms dismissed by healthcare providers, [...]
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46 per cent and improved survival compared to trastuzumab alone. The findings provide long-term evidence that T-DM1 is an effective adjuvant treatment for this [...]
Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights. This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict which are most likely to develop into euploid blastocysts—embryos with the correct number of chromosomes—during IVF treatment. By providing these insights early in the process, Euploidy Insights is set [...]
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and ideas beyond breast cancer, as similar protein regions are involved in many other diseases. The study focuses on what is known as the oestrogen receptor, a protein linked in [...]
The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women's health innovation. We will be celebrating some of the best examples of leadership, innovation and impact in key areas that affect women's health and wellbeing. New technology and ways of working are helping to redefine what [...]
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
















